NUWELLIS, INC. Operating Lease, Right-of-Use Asset, Amortization Expense
NUWELLIS, INC. (NUWE) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $217.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-03-11
- NUWELLIS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $56.00K.
- NUWELLIS, INC. operating lease, right-of-use asset, amortization expense for the quarter ending 2024-12-31 was -$150.00K.
- NUWELLIS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2025 was $217.00K.
- NUWELLIS, INC. operating lease, right-of-use asset, amortization expense for fiscal 2024 was $0.00.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $217.00K 10-K · filed 2026-03-11 | |
| 2025-09-30 | $161.00K 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11 | $0.00 10-K · filed 2026-03-11 | |
| 2024-09-30 | $150.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |